Status:
COMPLETED
Near InfraRed Fluorescence Using Indocyanine Green and Magnetic Resonance Lymphography of Lymphatic Transport
Lead Sponsor:
University of Rochester
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18-89 years
Phase:
PHASE1
Brief Summary
Lymphatic transport will be examined using Near InfraRed Indocyanine Green fluorescence imaging (NIR-ICG) and magnetic resonance lymphography (MRL) of the upper extremities. The purpose of the study i...
Detailed Description
Lymphedema from various etiologies (i.e. infection, cancer, surgery, and rheumatoid arthritis) remains a major health concern. Efforts to develop effective treatments for this condition have been limi...
Eligibility Criteria
Inclusion
- Ability to provide written informed consent.
- Subjects must be 18 years old or older.
Exclusion
- Active systemic disorders or inflammatory conditions (i.e., chronic infections with hepatitis B, hepatitis C or HIV) that would confound the study results.
- Known sensitivity to iodine because of residual iodide in indocyanine green
- Known sensitivity to gadolinium
- Any history of kidney disease
- Pregnant women should not participate; pregnancy tests will not be performed.
Key Trial Info
Start Date :
December 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2020
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT04046146
Start Date
December 15 2019
End Date
March 15 2020
Last Update
September 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rochester
Rochester, New York, United States, 14642